The pathway from early clinical phases to commercial is not straightforward, particularly for complex OSD products. As the project gets closer to the market – and with patients waiting for life-changing medicines – the need for a clear path to market becomes even more important.

From tech transfer complexities and issues arising in scaling to meeting unique packaging needs, there are many hurdles that must be carefully traversed to achieve a successful launch on time and without delay.

With a detailed map of the journey ahead, complex OSD manufacturers can anticipate and prepare for potential roadblocks, using an arsenal of tools to simplify their journey to market. By developing robust processes, utilizing operational excellence protocols and innovative solutions, controlling critical quality attributes (CQA) by process analytical technologies (PAT) and applying real time data sharing, including Real Time Release Testing (RTRT), the pathway to patients can be simplified and streamlined.

In this webinar, global Pfizer OSD scientists and manufacturing experts will share their unique insights on:

• The difficulties complex OSD manufacturers can expect as their product progresses.
• The importance of having the capabilities to support the unique needs of complex OSDs as the project scales.
• The need for experience and expertise to proactively identify and prepare for the risks ahead.
• Strategies that can be applied to minimize risk and simplify the journey as the project scales.